Lynette Kiers
YOU?
Author Swipe
View article: Evaluation and treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy
Evaluation and treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy Open
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an inflammatory, immune-mediated neuropathy of the peripheral nerves and nerve roots. CIDP is unlikely to be a discrete disease entity, but rather a spectrum of related co…
View article: 2722 Use of subcutaneous immunoglobulin in the maintenance treatment of CIDP: a single-centre experience
2722 Use of subcutaneous immunoglobulin in the maintenance treatment of CIDP: a single-centre experience Open
Objectives To review treatment efficacy, side effects and satisfaction among chronic inflammatory demyelinating polyneuropathy (CIDP) patients treated at the Royal Melbourne Hospital with subcutaneous immunoglobulin (SCIg). Methods We perf…
View article: 2822 From hospital to home: supporting chronic inflammatory demyelinating polyneuropathy patients on subcutaneous immunoglobulin therapy
2822 From hospital to home: supporting chronic inflammatory demyelinating polyneuropathy patients on subcutaneous immunoglobulin therapy Open
Objectives We review consumer satisfaction with the support provided to those with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with subcutaneous immunoglobulin (SCIg) at our hospital. Methods We performed a chart revie…
View article: Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study Open
Background Intramuscular injections of botulinum toxin A (BTX-A) have been used in the treatment of sleep bruxism (SB) however controlled trials are limited and the optimal injection strategy and dose is not known. Methods This double-blin…
View article: Electrodiagnostic subtyping in <scp>Guillain‐Barré</scp> syndrome: Use of criteria in practice based on a survey study in <scp>IGOS</scp>
Electrodiagnostic subtyping in <span>Guillain‐Barré</span> syndrome: Use of criteria in practice based on a survey study in <span>IGOS</span> Open
Electrodiagnostic (EDx) studies are helpful in diagnosing and subtyping of Guillain‐Barré syndrome (GBS). Published criteria for differentiation into GBS subtypes focus on cutoff values, but other items receive less attention, although the…
View article: <scp>Guillain‐Barré</scp> Syndrome in an Australian State Using Both <scp>mRNA</scp> and Adenovirus‐Vector <scp>SARS‐CoV</scp>‐2 Vaccines
<span>Guillain‐Barré</span> Syndrome in an Australian State Using Both <span>mRNA</span> and Adenovirus‐Vector <span>SARS‐CoV</span>‐2 Vaccines Open
We read the two recent reports of Guillain–Barré syndrome (GBS) following SARS-CoV-2 vaccination with interest and were inspired to review GBS reports submitted to our enhanced spontaneous surveillance system in Victoria, Australia (SAEFVI…
View article: Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy
Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy Open
Objective To explore the diagnostic utility and cost effectiveness of whole exome sequencing ( WES ) in a cohort of individuals with peripheral neuropathy. Methods Singleton WES was performed in individuals recruited though one pediatric a…
View article: Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy Open
Objective The objective of the study was to profile leukocyte markers modulated during intravenous immunoglobulin ( IVI g) treatment, and to identify markers and immune pathways associated with clinical efficacy of IVI g for chronic inflam…
View article: Multifocal Motor Neuropathy Presenting as Pseudodystonia
Multifocal Motor Neuropathy Presenting as Pseudodystonia Open
View Supplementary Video 1 View Supplementary Video 2 Multifocal motor neuropathy (MMN) is an immune‐mediated neuropathy. Wasting and weakness typically dominate the clinical presentation. We describe four cases presenting with prominent c…